About
Plasma Products, Vaccines
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingBiologics & BiopharmaceuticalContract ManufacturingVaccineContract ManufacturingContract ResearchContract Manufacturing
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
12
As Collaborator
3
Total Enrollment
2,757
By Phase
PHASE3: 3PHASE1/PHASE2: 2PHASE1: 6PHASE2: 1NA: 1PHASE4: 1
By Status
RECRUITING: 5UNKNOWN: 4ACTIVE_NOT_RECRUITING: 3COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
Hover over trial bars to see details
Recent Trials
NCT07054099Lead Sponsor
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
PHASE3Not yet recruiting
474 participants
Started: Mar 31, 2026 · Completed: Jul 31, 2036
NCT06997627Lead Sponsor
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
PHASE1/PHASE2Recruiting
120 participants
Started: Jun 5, 2025 · Completed: May 31, 2026
NCT06858397Lead Sponsor
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
PHASE1/PHASE2Recruiting
18 participants
Started: May 14, 2025 · Completed: Aug 30, 2028
NCT06567769Lead Sponsor
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
PHASE1Recruiting
9 participants
Started: Nov 21, 2024 · Completed: Jun 30, 2027
NCT06001749Collaborator
Psilocybin in Cancer Pain Study
PHASE2Recruiting
15 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Yongin, Korea
Map
Loading map...